Posts tagged: Avacta Group
Betaville IntelligenceThursday, 4 June 2020, 5:48 am
Avacta Group, the Aim-listed developer of a saliva test for Coronavirus, is said to be looking to tap investors for up to £30 million.
People following the situation said that Avacta is working with brokers from finnCap an equity capital raising via an accelerated bookbuild.
It's thought Avacta is considering issuing new shares at between 110p and 120p a share with a view to raising as much as £30 million...
Read more...
Wednesday, 20 May 2020, 7:42 am
Hitting the RNS this morning is some fresh news about how a company backed by Mahmud Kamani has signed a deal to distribute some Covid-19 tests being developed by Avacta...
Read more...
Betaville IntelligenceSaturday, 19 October 2019, 7:17 am
Oh look - I see Avacta Group, the Aim-listed biotechnology company, has effectively confirmed little old Betaville's RARE alert from yesterday morning. Below is the link:
https://www.investegate.co.uk/avacta-group-plc--avct-/rns/proposed-placing---subscription-to-raise-up-to--9m/201910181206574138Q/..
Read more...
Betaville IntelligenceFriday, 18 October 2019, 8:48 am
Avacta Group, the Aim-listed biotechnology company, is close to announcing a multi-million pound equity fundraising.
Sources familiar with the matter said Avacta is tapping up investors for up to £7 million, possibly via a placing.
It's believed Avacta is looking to raise the new capital at around 15p a share, said sources familiar with the matter...
Read more...